Europe's first human embryonic stem cell trial approved

A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.

Regenerative powers in the animal kingdom explored

Why can one animal re-grow tissues and recover function after injury, while another animal (such as a human being) cannot? This is a central question of regenerative biology, a field that has captured the imagination of scientists ...

Suit against federal stem cell research dismissed

(AP) -- A lawsuit that had threatened to end the Obama administration's funding of embryonic stem cell research was thrown out Wednesday, allowing the U.S. to continue supporting a search for cures to deadly diseases over ...

The role of metal ions in amyotrophic lateral sclerosis

(PhysOrg.com) -- Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects motor neurons in the spinal cord, leading to muscle weakness, paralysis, and ...

Tracking neural stem cells

(PhysOrg.com) -- Magnetic nanoparticles could be used to track neural stem cells after a transplant in order to monitor how the cells heal spinal injuries, say UCL scientsts.

Stem cell research breaks new ground in 2010

Two US companies this year broke new ground by winning regulatory approval to start the first experiments using embryonic stem cells on humans suffering from spinal cord injury and blindness.

page 15 from 18